載入...
Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution
BACKGROUND: Doxorubicin is the key drug for treatment of advanced soft tissue sarcoma (STS). The appropriate dosage of doxorubicin, regarding monotherapy or the role of combination therapy, is unclear. METHODS: We retrospectively reviewed patients with advanced or metastatic STS of nonextremities wh...
Na minha lista:
| 發表在: | Sarcoma |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5932429/ https://ncbi.nlm.nih.gov/pubmed/29849480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8926598 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|